Vall d'Hebron Hospital

Barcelona 08035

1 studies enrolling now · 10 studies all time

What they study most

Acute Ischemic Stroke, Aneurysmal Subarachnoid Hemorrhage, Deep Venous Thrombosis, Development of Reporting System for Molecular Diagnosis, Focal Epilepsy, Incorporate Molecular Diagnosis Into Diagnostic Standards, Intracranial Hemorrhage Ruptured Aneurysm, Ischemic Attack, Transient, Melanoma, Non-Alcoholic Steatohepatitis (NASH), Pulmonary Embolism, Thrombotic Disease

Studies at this site

• Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling
• International Subarachnoid Aneurysm Trial II — Running, not enrolling
• Derazantinib and Atezolizumab in Patients With Urothelial Cancer — Completed
• Phase 2b Study in NASH to Assess IVA337 — Completed
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy — Completed
• Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke — Completed
• Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping — Completed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early